Clindamycin has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents. Therefore it should be used with caution in patients receiving such agents.
In vitro antagonism has been demonstrated between Clindamycin and Erythromycin, because it is have clinically significant possibility, it may be advisable to separate the time of administration of each drug.